iTOL-102

N/A

Report date: 2025/04/17 16:06:02

Base Information

Drug NameiTOL-102
Drug Alias NameAllogeneic Stem Cell-Derived Pancreatic IsletiTOL-102
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionStem cell replacementsPancreatic beta cell replacements
TargetsNot applicable
Therapy Area/IndicationsDiabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesiTolerance Inc
China Registration ClassN/A

Develop Information

Active CompaniesiTolerance Inc
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 1
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A